Quantcast

Latest Multiple drug resistance Stories

2008-10-14 09:00:45

BOSTON, Oct. 14 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced the Company's lead product, amadacycline, formerly PTK 0796, a first-in-class aminomethylcycline, will be the subject of a Late Breaker poster presentation at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). ICAAC will be held in Washington, D.C. from October 25 - October 28, 2008. More information on the poster session at ICAAC: Sunday, October 26, 12:15 - 1:15 pm EST...

2008-09-19 03:00:30

A concerted global response is needed against the rising rate of bacterial resistance or "we will return to the pre-antibiotic era," a Swedish researcher said. Otto Cars of Uppsala University Hospital in Sweden and colleagues said in an editorial in the British Medical Journal that all antibiotic use "uses up" some of the effectiveness of that antibiotic, diminishing the ability to use it in the future, therefore, antibiotics can no longer be considered as a "renewable source." Existing...

2008-09-17 09:01:00

Research and Markets (http://www.researchandmarkets.com/research/1e8682/cancer_drug_resist) has announced the addition of the "Cancer Drug Resistance" report to their offering. Resistance mechanisms, resistance biomarkers, current & pipeline cancer drugs and strategies to combat drug resistance A detailed and comprehensive review of cancer drug resistance Drug resistance is the single most important cause of cancer treatment failure and carries a massive burden to patients,...

2008-09-09 09:00:09

NEW HAVEN, Conn., Sept. 9 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced today the formation of its Clinical Advisory Board. The Board, comprised of six infectious disease specialists, will provide oversight and counsel on matters related to the Company's clinical development programs. Dr. Robert C. Moellering,...

2008-08-27 09:01:28

NEW HAVEN, Conn., Aug. 27 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced today that Susan Froshauer, PhD, President and Chief Executive Officer, is scheduled to present at the Thomas Weisel Partners Healthcare Conference on September 4, 2008, at 9:45 A.M. The conference will be held from September 3-5, 2008 at the...

2008-08-18 09:01:01

UNION CITY, Calif. and SHANGHAI, China, Aug. 18 /PRNewswire-FirstCall/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced the nomination of MRX- I as its first preclinical development candidate. MRX-I is an antibacterial molecule targeting multi-drug resistant gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Simultaneously, the company expanded its operations in China to...

2008-07-31 09:01:26

NEW HAVEN, Conn., July 31 /PRNewswire-FirstCall/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced today that George M. Milne, Jr., Ph.D., has been appointed Executive Chairman of the Board of Directors. Dr. Milne succeeds Harry H. Penner, Jr., who served as Board Chairman since the Company's first Board meeting in January, 2001....

2008-07-29 09:01:15

Nafsika Georgopapadakou, PhD, Vice President, Research at NovaBay Pharmaceuticals, Inc., (AMEX: NBY), was interviewed by television stations across the country this week to discuss the growing problem of methicillin-resistant Staphylococcus aureus (MRSA), the rise in "super bugs" (multi-drug-resistant pathogens) and steps that can be taken to prevent systemic bacterial infections. The interviews were part of a broad patient education initiative undertaken by NovaBay to create not only...

2008-07-24 00:00:18

THE latest drive to cut the number of people given antibiotics for common coughs and colds begins today. Figures show that a quarter of people in England and Wales visit GPs every year with symptoms of respiratory tract infections. Such patients account for 60 per cent of all antibiotic prescribing in general practice - a figure that health experts are trying to reduce. Over-prescribing has been linked to the emergence of "superbugs", which are resistant to most forms of the drug....

2008-07-01 09:00:04

By FRANK JORDANS By Frank Jordans The Associated Press GENEVA A new test to quickly diagnose drug-resistant forms of tuberculosis will be rolled out in four African countries this year, the World Health Organization said Monday. The DNA-based test will cut the time it takes to detect multi- drug resistant TB from up to four months to a matter of hours, the director of WHO's tuberculosis program said . Dr. Mario Raviglione said testing is currently "one of the major bottlenecks"...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related